High blood pressure and diabetes mellitus: Are all antihypertensive drugs created equal?

Archives of Internal Medicine

Volumn 160, Issue 16, 2000, Pages 2447-2452

  Grossman, E ^a   Messerli, F H ^a   Goldbourt, U ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK;

EID: 0034638139     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.16.2447     Document Type: Article

References (47)

1. Type 2 diabetes mellitus: Greater cardiovascular risks and greater benefits of therapy
2. Diabetic and hypertensive heart disease
3. Diabetes mellitus and hypertension
4. Hypertension and mortality in diabetic and non-diabetic Finnish men
5. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
6. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy
7. Hypotensive therapy reduces microvascular albumin leakage in insulin-dependent diabetic patients with nephropathy
8. Hypertension in diabetic patients: An overview of interventional studies to preserve renal function
9. National High Blood Pressure Education Program Working Group report on hypertension in diabetes
10. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria: European Microalbuminuria Captopril Study Group
11. Comparative effects of ramipril and nitrendipine on albuminuria in hypertensive patients with non-insulin-dependent diabetes mellitus and impaired renal function
12. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria
13. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM
14. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
15. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension: Systolic Hypertension in Europe Trial Investigators
16. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
17. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension: Systolic Hypertension in the Elderly Program Cooperative Research Group
18. Chinese trial on isolated systolic hypertension in the elderly
19. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension: Systolic Hypertension in China (Syst-China) Collaborative Group
20. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
21. Diabetes mellitus as a risk factor for death from stroke: Prospective study of the middle-aged Finnish population
22. NIDDM and blood pressure as risk factors for poor cognitive performance: The Framingham Study
23. Determinants of progressive renal disease in diabetes mellitus
24. Increased incidence of retinopathy in diabetics with elevated blood pressure: A six-year follow-up study in Pima Indians
25. Putative risk factors associated with retinopathy in patients with diabetes diagnosed at or after 30 years of age
26. Blood pressure and the progression of mild background diabetic retinopathy
27. High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients
28. Risk factors for coronary heart disease mortality among persons with diabetes
29. Left ventricular mass in diabetes-hypertension
30. How far should blood pressure be reduced in diabetic hypertensive patients?
31. Effect of antihypertensive treatment on kidney function in diabetic nephropathy
32. The impact of hypertension and antihypertensive treatment on the course and prognosis of diabetic nephropathy
33. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
34. All-cause mortality in the Hypertension Detection and Follow-up Program: Findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality
35. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
36. Long-term effects of antihypertensive agents on proteinuria and renal function
37. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: A 7-year follow-up study
38. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
39. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis
40. Treatment of diabetic patients with hypertension
41. Are β-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review
42. Randomized trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
43. Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selection
44. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy
45. Angiotensin converting enzyme inhibitors and calcium antagonists alone or combined: Does the progression of diabetic renal disease differ?
46. The benefits of ACE inhibitors and calcium antagonists in slowing progressive renal failure: Focus on fixed-dose combination antihypertensive therapy